Vicept Therapeutics
Latest round
- Series A
Last raised
- Jun 2010
Total raised
- $10M
Investors
- 3
About Vicept Therapeutics
Based in US, Vicept is a biopharmaceutical company focused on the development of the first effective topically-applied treatment for the skin redness associated with rosacea, and pursuing additional indications that include the treatment and prevention of actinic (solar) purpura and peri-procedural bruising of the skin.
Who invested in Vicept Therapeutics
3 investors across 1 round
See all investors in Vicept Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 30, 2010
Amount
$10M
Investors
Questions about Vicept Therapeutics
Who invested in Vicept Therapeutics?
Vicept Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vicept Therapeutics raised?
Vicept Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vicept Therapeutics last raise money?
Vicept Therapeutics's most recent round on record is a Series A, in Jun 2010.
What does Vicept Therapeutics do?
Based in US, Vicept is a biopharmaceutical company focused on the development of the first effective topically-applied treatment for the skin redness associated with rosacea, and pursuing additional indications that include the treatment and prevention of actinic (solar) purpura and peri-procedural bruising of the skin.
Where is Vicept Therapeutics headquartered?
Vicept Therapeutics is headquartered in Malvern, US.
Which VCs invest in companies like Vicept Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vicept Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vicept Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.